2014—2016年衡阳市中心医院泌尿生殖系统药物的使用情况分析

Analysis on the utilization of genitourinary system drugs in Hengyang Central Hospital from 2014 to 2016

目的对衡阳市中心医院泌尿生殖系统药物的使用情况进行分析,为临床合理用药提供参考。方法对2014—2016年衡阳市中心医院泌尿生殖系统药物的种类、销售金额、用药频度(DDDs)、限定日费用(DDC)和排序比(B/A)等进行统计分析。结果 2014—2016年泌尿生殖系统药物的种类、销售金额、构成比和DDDs基本不变。中成药的品种数、销售金额和DDDs均排名第一;而妇科用抗感染药和灭菌药构成比最小。DDDs一直排名前10的药物有螺内酯片、盐酸坦洛新缓释片、滋肾健脑液、保妇康栓、呋塞米片、百艾洗液、非那雄胺片7个品种。呋塞米片、氢氯噻嗪片、螺内酯片各年DDC均较低,2014—2016年DDC最高的药物分别是来曲唑片和复方大红袍止血片。非那雄胺片/分散片、托拉塞米片、戊酸雌二醇片、氢氯噻嗪片、呋塞米注射液这5种药物的B/A接近于1.0。结论衡阳市中心医院泌尿生殖系统药物的使用基本合理,中成药一直占据重要地位,临床治疗中应根据患者的具体情况合理选择药物,以提高治疗的安全性、有效性和经济性。

Objective To analyze the utilization of genitourinary system drugs in Hengyang Central Hospital, and in order to provide reference for clinical rational use of drugs. Methods Varieties, consumption sum, frequency of drug use （DDDs）, defined daily cost （DDC）, and sequence ratio （B/A） of genitourinary system drugs in Hengyang Central Hospital from 2014 to 2016 were statistically analyzed. Results Varieties, consumption sum, constituent ratio, and DDDs showed a stable tendency from 2014 to 2016. Variety number, consumption sum, and DDDs of Chinese patent medicine dominated the first places for 3 years, while the constituent ratio of gynecological antiinfectives and antiseptics always ranked the last. Spironolactone Tablets, Tamsulosin Hydrochloride Sustained Release Tablets, Zishen Jiannao Oral Liquid, Baofukang Shuan, Furosemide Tablets, Multi-love Lotion, and Finasteride Tablets ranked the top 10. DDC of Furosemide Tablets, Hydrochlorothiazide Tablets, and Spironolactone Tablets were low in every year. DDC of Letrozol Tablets and Fufang Dahongpao Zhixue Tablets for injection were the highest from 2014 to 2016. B/A of Finasteride Tablets/Dispersible Tablets, Torasemide Tablets, Estradiol Valerate Tablets, Hydrochlorothiazide Tablets, and Furosemide Injection were near to 1.0. Conclusion The utilization of genitourinary system drugs is basically rational in Hengyang Central Hospital. Chinese patent medicine have occupied the most important position among genitourinary system drugs. The drugs should be selected reasonably according to the specific condition of patients in clinical treatment, in order to improve the safety, effectiveness, and economy of treatment.